Diligent Qualification Platform Terms of Use

Effective Date: May 2021

The terms “Diligent,” “we,” “us” and “our” refer to Diligent Pharma, LLC (“Diligent Pharma”) and its affiliates.  Use of the Diligent Qualification Platform (“Diligent”) is subject to the following terms and conditions (“Terms of Use”) that you affirmatively accept by using Diligent.  Please read these Terms of Use carefully and ensure that you understand them before you begin use. If you do not agree to the Terms of Use, you should not use Diligent.

THESE TERMS EXEMPT DILIGENT PHARMA AND OTHER PERSONS FROM LIABILITY OR LIMITS THEIR LIABILITY AND CONTAINS OTHER IMPORTANT PROVISIONS THAT YOU SHOULD READ.

DILIGENT PHARMA MAY UPDATE THESE TERMS OF USE AT ANY TIME, IN ITS SOLE DISCRETION. EACH TIME YOU USE DILIGENT, THESE TERMS, AS THEY THEN READ, WILL GOVERN YOUR USE. IN THE EVENT OF AN UPDATE, YOUR CONTINUED USE OF DILIGENT FOLLOWING THE POSTING OF ANY CHANGES, SIGNALS YOUR UNDERSTANDING OF, AND AGREEMENT TO, SUCH CHANGES.

Ability to Accept Terms of Use.

Diligent is intended for use only by individuals who are at least 18 years old and by using Diligent you represent that you are at least 18 years old.  If you are consenting to these Terms of Use on behalf of a legal entity, you represent and warrant that you have the authority to consent to these Terms of Use on behalf of the entity.

Scope

Diligent is a platform whereby companies (“Consumers”) seeking service from providers of clinical services (“Providers”) can search for Providers and request RFI packages.  All Providers and Consumers are considered “users” for purposes of these Terms of Use.  These Terms of Use are intended to supplement and not to replace existing agreements between users and Diligent Pharma regarding the services offered.

All Providers placing content on Diligent are independent contractors and are not employees, subcontractors or agents of Diligent Pharma. Diligent Pharma has no responsibility to any Provider employees or contractors as an employer. Diligent Pharma is not involved with nor does it have any control over the actual performance of any services by Providers, nor does it guarantee the timeliness or quality of those services. Users who agree to have another user perform services should make an independent determination regarding whether all applicable laws and regulations are being met. Use of Diligent is done at user discretion and at their own risk. Diligent Pharma is not responsible for any harm that may result or arise out of any service connected via Diligent. Diligent Pharma is under no obligation to facilitate, become involved with or negotiate a resolution in any dispute between users.

It is the user’s responsibility to ascertain and obey all applicable local, state, federal and international laws in regard to the receipt and use of any service or information obtained via Diligent.

The term “Authorized Master User” refers to Consumers or Providers employee or representatives who is authorized by Consumers or Providers to use the platform and has been supplied user credentials.  The “Authorized Master User” will have permissions and rights assigned within the platform that allows the “Authorized Master User” to create additional “Authorized Users” (or “Client Child Users” as defined within the platform) of Consumers or Providers for access to the Platform.  The term “Authorized User” refers to Consumers or Providers employees who have been authorized by Consumers or Providers to use the platform and have been supplied user credentials by the Consumers or Providers “Authorized Master User”.  The “Authorized Master User” assumes all responsibilities for managing the Consumers or Providers user community. These responsibilities include but are not limited to user account creation, user password assignment, user profile content maintenance, profile content maintenance and user rights and permissions assignments (including without limitation assigning user permissions to enable the release or request of information to or from any other user, Consumer or Provider).  All acts and omissions of the Authorized User community for Consumers or Providers shall be deemed acts or omissions of Consumers or Providers. Users are solely responsible for any use of Diligent that is enabled by means of their access information, even if it is unauthorized.  If a user suspects unauthorized activity or a security breach, they must notify Diligent Pharma immediately.

Users represent that they are not located in a country that is subject to a US Government embargo or that has been designated by the US Government as a terrorist supporting country and that they are not listed on any US Government list of prohibited or restricted parties.

Accuracy, Completeness and Timeliness of Information

Although Diligent Pharma makes reasonable efforts to ensure that all information included on Diligent is correct, accuracy cannot be guaranteed and Diligent Pharma does not assume any responsibility or obligation for the accuracy, completeness, timeliness, or authenticity of information on Diligent. Information obtained via Diligent should not be relied upon or used as the sole basis for making significant decisions without consulting primary or more accurate, complete or timely sources of information.

Use of the Diligent Platform

The content included on Diligent, such as text, design, graphics, logos, icons, images, audio clips, downloads, interfaces, code, software, any intellectual property, and the selection and arrangement of any of these, are the exclusive property of Diligent Pharma, its affiliates, its licensors and/or its content providers and is protected by copyright, registered trademark, and other applicable laws.

Materials on Diligent or obtained through Diligent may be used only for internal business purposes and not as part of any service offerings to third parties. Improper use of information and improper use of any hardware or software with the intent to damage or interfere with the proper working of Diligent or to surreptitiously intercept any system, data or personal information from Diligent, is strictly prohibited. Users may not interrupt or attempt to interrupt the operation of Diligent in any way and Diligent Pharma reserves the right, in its sole discretion, to terminate access to or use of Diligent at any time without notice.  Termination of access or use of Diligent will not waive or affect any right or relief to which Diligent Pharma may be entitled at law or in equity.

Users may not provide false e-mail addresses or impersonate any person or entity, or otherwise provide misleading information in connection with their use of Diligent. Each user entity must designate an employee or agent to act as the contact person for receiving and managing all communications related to Diligent. The contact person may be changed upon written notice to Diligent Pharma.

All remarks, suggestions, ideas, graphics, or other information communicated to Diligent Pharma through or in relation to Diligent (other than personally identifiable information or trademarked or confidential information of service providers) will forever be the property of Diligent Pharma. Diligent Pharma will be entitled to use such submissions for commercial or other purpose without compensation, credits or notice to the submitter or to any other person. Diligent Pharma will not incur any liability as a result of any similarities that may appear in its future business operations, services or products. By submitting unsolicited submissions to Diligent Pharma the submitter waives the right to make any claim against Diligent Pharma relating to the submission.

Any use of information obtained from Diligent will be consistent with the Privacy Policy located on the Diligent Pharma website and the terms of any agreements executed between the user and Diligent Pharma regarding the services offered. Possible evidence of use of Diligent for illegal purposes will be provided to law enforcement authorities.

Diligent Pharma may from time to time develop patches or fixes or may find it necessary to install updates, upgrades and other modifications to Diligent. These may from time to time be automatically installed without providing any additional notice or receiving any additional consent and users consent to this automatic update. If a user fails to install any software updates or other required item, use of Diligent may be compromised.

Intellectual Property

Intellectual property of Diligent Pharma, including trademarks, logos, and service marks as displayed on Diligent are registered and unregistered trademarks of Diligent Pharma, its affiliates, its licensors, its content providers, and other third parties. All such trademarks, logos, and service marks are the property of their respective owners. Nothing on Diligent shall be construed as granting by implication, estoppel, or otherwise, any license or right to use any trademark, logo, or service mark displayed on Diligent without the owner’s prior written permission, except as otherwise described herein. The receipt of information and/or material included on Diligent, is conditioned on the user’s prohibition from modifying or deleting any copyright, registered trademark or other proprietary notice that appears on the information. Any other use of information and/or material contained on Diligent, including, but not limited to, the modification, distribution, transmission, performance, broadcast, publication, licensing, reverse engineering, transfer or sale of, or the creation of derivative works from, any material, information, software, or services obtained from Diligent, is expressly prohibited. Diligent Pharma, its affiliates, its licensors and/or its content providers retain full and complete title to the information and material provided on Diligent, including all associated intellectual property rights. Diligent Pharma neither warrants nor represents that use of information and/or material from Diligent will not infringe rights of third parties not affiliated with Diligent Pharma. Diligent Pharma reserves all rights not expressly granted in and to Diligent. Only authorized individuals may use Diligent. Authorized individuals include: (i) employees and individual contractors of users acting under direct user supervision, and (ii) the personnel of outsourcers who are performing an internal business function for a user and on the condition that the outsourcer has expressly agreed that its use of Diligent is subject to these Terms of Use. Users remain responsible for their contractors and outsourcers’ use of Diligent in violation of these Terms of Use. Diligent Pharma may use subcontractors to perform its obligations hereunder. These Terms of Use do not govern your use of the Diligent website, they apply only to the use and access to Diligent.

Diligent Pharma respects the intellectual property rights of others and may remove content that it believes may infringe the intellectual property rights of others. If you believe that Diligent has infringed your intellectual property rights, please notify Diligent Pharma and provide the following information:

• An identification of the intellectual property claimed to have been infringed, including copies of registration certificates, if available.
• A detailed description of the material that you claim is infringing, so that Diligent Pharma may locate it.
• Your address, telephone number, and email address.
• A statement by you that you have a good faith belief that the allegedly infringing use is not authorized by the intellectual property rights owner, its agent, or the law.
• A statement, made under penalty of perjury, by you that the above information is accurate and that you are authorized to act on behalf of the owner of the intellectual property rights involved.

Please send the foregoing to the following address:

Diligent Pharma Inc.
179 Nassau Street, Suite 3A
Princeton, NJ 08542
USA

DISCLAIMERS
USE OF DILIGENT IS AT THE USER’S SOLE RISK.  DILIGENT IS PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS.  DILIGENT PHARMA RESERVES THE RIGHT TO RESTRICT OR TERMINATE ACCESS TO DILIGENT OR ANY FEATURE OR PART THEREOF AT ANY TIME.  DILIGENT PHARMA EXPRESSLY DISCLAIMS ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO: IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE AND ANY WARRANTIES THAT MATERIALS ON DILIGENT ARE NONINFRINGING, AS WELL AS WARRANTIES IMPLIED FROM A COURSE OF PERFORMANCE OR COURSE OF DEALING; THAT ACCESS TO DILIGENT WILL BE UNINTERRUPTED OR ERROR-FREE; THAT DILIGENT WILL BE SECURE; THAT DILIGENT WILL BE VIRUS-FREE; OR THAT INFORMATION ON DILIGENT WILL BE COMPLETE, ACCURATE, TIMELY, OR AUTHENTIC. USERS ARE SOLELY RESPONSIBLE FOR ANY DAMAGE TO THEIR COMPUTER SYSTEM OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OR UPLOAD OF ANY MATERIALS.  NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED FROM DILIGENT PHARMA OR THROUGH OR FROM DILIGENT SHALL CREATE ANY WARRANTY OF ANY KIND. ALL THIRD PARTY PRODUCTS PROVIDED IN CONNECTION WITH DILIGENT ARE PROVIDED AS IS.  ANY WARRANTY THAT CANNOT BE EXCLUDED UNDER APPLICABLE LAW IS LIMITED IN DURATION TO 30 DAYS FROM THE EVENT GIVING RISE TO THE WARRANTY.

LIMITATION OF LIABILITY

DILIGENT USERS HEREBY ACKNOWLEDGE THAT ANY INFORMATION SENT OR RECEIVED MAY NOT BE SECURE AND MAY BE INTERCEPTED OR OBTAINED BY UNAUTHORIZED PARTIES. IT IS UNDERSTOOD AND ACKNOWLEDGED THAT FULL RESPONSIBILITY FOR USE OF DILIGENT IS AT THE USER’S SOLE RISK AND DISCRETION.

DILIGENT PHARMA, ITS AFFILIATES OR BUSINESS PARTNERS WILL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, PUNITIVE, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR OTHER DAMAGES ARISING OUT OF OR IN ANY WAY RELATED TO DILIGENT OR WITH THE DELAY OR INABILITY TO USE DILIGENT, OR FOR ANY INFORMATION OR SERVICES ADVERTISED IN OR OBTAINED THROUGH DILIGENT, OR OTHERWISE ARISING OUT OF THE USE OF DILIGENT, WHETHER BASED ON CONTRACT, TORT, STRICT LIABILITY OR OTHERWISE, EVEN IF DILIGENT PHARMA OR ANY OF ITS AFFILIATES OR BUSINESS PARTNERS HAS BEEN ADVISED OF THE POSSIBILITY OF DAMAGES AND REGARDLESS OF THE EXISTENCE OF NEGLIGENCE. THIS DISCLAIMER APPLIES, WITHOUT LIMITATION, TO ANY DAMAGES OR INJURY ARISING FROM ANY FAILURE OF PERFORMANCE, ERROR, OMISSION, INTERRUPTION, DELETION, DEFECT, DELAY IN OPERATION OR TRANSMISSION, COMPUTER VIRUSES, FILE CORRUPTION, COMMUNICATION-LINE FAILURE, NETWORK OR SYSTEM OUTAGE, ANY LOSS OF PROFITS, THEFT, DESTRUCTION, UNAUTHORIZED ACCESS TO, ALTERATION OF, LOSS OF USE OF ANY RECORD OR DATA, ASSAULT, BATTERY, OR ANY OTHER TANGIBLE OR INTANGIBLE LOSS.

USERS OF DILIGENT SPECIFICALLY ACKNOWLEDGE AND AGREE THAT DILIGENT PHARMA AND ITS BUSINESS PARTNERS SHALL NOT BE LIABLE FOR ANY DEFAMATORY, OFFENSIVE, ILLEGAL, OR OTHERWISE INAPPROPRIATE OR OBJECTIONABLE CONDUCT OF ANY USER.  THE MAXIMUM AMOUNT OF DIRECT DAMAGES RECOVERABLE FOR ALL EVENTS, ACTS OR OMISSIONS HEREUNDER OR OTHERWISE, EXCLUDING EVENTS INVOLVING A PARTY’S FRAUD OR WILLFUL MISCONDUCT, SHALL NOT EXCEED THE TOTAL CASH AMOUNT PAYABLE BY A USER TO DILIGENT PHARMA UNDER THE AGREEMENT SIGNED IN RELATION TO THE SERVICES PROVIDED. IN NO EVENT WILL THE MEASURE OF DAMAGES INCLUDE, NOR WILL A PARTY BE LIABLE FOR, ANY AMOUNTS FOR LOSS OF INCOME, PROFIT OR SAVINGS, OR INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES OF ANY PARTY, INCLUDING CLAIMS OR DAMAGES OF THIRD PARTIES, EVEN IF THE PARTIES HAVE BEEN ADVISED OF THE LIKELIHOOD OF SUCH DAMAGES.

USERS OF DILIGENT AGREE THAT ANY CAUSE OF ACTION ARISING OUT OF OR RELATED TO DILIGENT MUST COMMENCE WITHIN SIX (6) MONTHS AFTER THE CAUSE OF ACTION ACCRUES OR THE CAUSE OF ACTION IS PERMANENTLY BARRED.  BECAUSE SOME JURISDICTIONS DO NOT ALLOW LIMITATIONS ON HOW LONG AN IMPLIED WARRANTY LASTS, THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, OR SHORTENING OF THE STATUTE OF LIMITATIONS PERIOD, ALL OR A PORTION OF THE ABOVE LIMITATIONS MAY NOT APPLY. Nothing in this Section precludes a party from seeking specific enforcement, injunctive relief or other equitable remedy. If these limitations as written are not permitted by applicable law, they shall apply to the extent permitted by applicable law.

Third Party Products

Any software, services, goods or other products or technology that are provided by a third party, or that are provided by Diligent Pharma but are: (i) identified by Diligent Pharma with a brand name or logo that is not a Diligent Pharma brand name or logo, or (ii) provided subject to a user’s agreement to the third party’s legal terms and conditions (“Third Party Products”) are subject to the terms of the license and other agreement terms of the third party.  Specifically, but without limitation, the operating system, virtualization and other general systems software may be a Third Party Product subject to separate licensing terms, conditions and restrictions of the third party providers. Users may be required to accept the end user license and other terms of the third party providers as a condition to use of the Third Party Products.

Indemnification
Users of Diligent agree to indemnify, defend and hold harmless Diligent Pharma and its officers, directors, employees, agents, licensors, and suppliers, from and against any and all losses, liabilities, expenses, damages and costs, including reasonable attorneys’ fees and court costs, arising or resulting from their use of Diligent or any services offered or accepted through Diligent and any violation of these Terms of Use. If technical disruption of Diligent or the systems supporting it occurs due to a user’s action or inaction, the user agrees to be responsible for any and all losses, liabilities, expenses, damages and costs, including reasonable attorneys’ fees and court costs, arising or resulting from that disruption. Diligent Pharma reserves the right, at its own expense, to assume exclusive defense and control of any matter otherwise subject to indemnification and, in such case, users agree to cooperate with Diligent Pharma in defense of such matter.

Confidentiality

The privacy of all users must be protected at all times. Diligent Pharma will maintain reasonable administrative, physical, and technical safeguards for protection of the security, confidentiality and integrity of Diligent. Upon request, Diligent Pharma will provide a description of its security measures for Diligent (the “Security Documentation”). Users acknowledge that the Security Documentation is sensitive confidential information of Diligent Pharma and agree not to disclose the Security Documentation to any third party or use the Security Documentation for any purpose other than evaluating the security of Diligent. Users are responsible for deciding if the security measures of Diligent Pharma meet the user’s requirements in light of the business goals and any laws or regulations applicable to the user’s business. Users agree that Diligent Pharma is not responsible for any harm as a result of a security incident arising from use of Diligent unless the incident resulted from Diligent Pharma’s failure to properly implement and maintain the security measures described in its Security Documentation.

Jurisdiction
Diligent is controlled by Diligent Pharma from its offices located within the United States of America and has been designed to comply with the laws of the United States. These Terms of Use shall be interpreted and construed in accordance with the laws of the State of Pennsylvania, USA without regard to principles of conflicts of the law thereof, and any disputes arising hereunder shall be adjudicated in the federal or state courts of Pennsylvania, USA to whose jurisdiction the parties hereto hereby irrevocably submit and as to venue the parties hereto hereby waive all objections.

Entire Agreement

These Terms of Use along with the agreements executed between users and Diligent Pharma regarding the services that will now be offered via Diligent (which are incorporated hereunder by reference), constitute the entire Agreement and supersedes all prior agreements, negotiations, representations and proposals, written and oral, relating thereto.

Severability
If any provision of these Terms of Use is unlawful, void or unenforceable, the remaining provisions shall remain in full force. In the event any provision of this document is found by an arbitrator or court of competent jurisdiction to exceed the limits permitted by any applicable law or to be invalid as written, it may be reformed to the extent necessary to make it reasonable and enforceable.

No Assignment

Users and the persons he/she represents may not assign these Terms of Use or the rights and obligations hereunder without the express prior written consent of Diligent Pharma, which may be withheld in Diligent Pharma’s discretion. Diligent Pharma may assign these Terms of Use and its rights and obligations hereunder without user consent or the consent.

How to Contact Us

Questions or comments about these Terms of Use or Diligent may be directed to: admin@diligentpharma.com